# PEnile Cancer Radio- and Immunotherapy CLinical Exploration Study

> **NCT03686332** · PHASE2 · COMPLETED · sponsor: **The Netherlands Cancer Institute** · enrollment: 32 (actual)

## Conditions studied

- Penile Cancer

## Interventions

- **DRUG:** Arm A: Atezolizumab and Radiotherapy
- **DRUG:** Arm B: Atezolizumab

## Key facts

- **NCT ID:** NCT03686332
- **Lead sponsor:** The Netherlands Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-25
- **Primary completion:** 2022-09-28
- **Final completion:** 2023-09-15
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2023-09-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03686332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03686332, "PEnile Cancer Radio- and Immunotherapy CLinical Exploration Study". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT03686332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*